Antiretroviral therapy coverage for PMTCT in Moldova

Moldova: Antiretroviral therapy coverage for PMTCT was 79.0% in 2024. ◆ Volatile

Latest (2024)
79.0%
Change on year
down 9.2%
World rank
43rd
of 84 countries
All-time high
92.0%
in 2022
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Moldova, 2000–2024

0204060801002000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 2 % of pregnant women living with HIV2004: 14 % of pregnant women living with HIV2005: 15 % of pregnant women living with HIV2006: 26 % of pregnant women living with HIV2007: 29 % of pregnant women living with HIV2008: 51 % of pregnant women living with HIV2009: 42 % of pregnant women living with HIV2010: 47 % of pregnant women living with HIV2011: 47 % of pregnant women living with HIV2012: 54 % of pregnant women living with HIV2013: 55 % of pregnant women living with HIV2014: 58 % of pregnant women living with HIV2015: 67 % of pregnant women living with HIV2016: 75 % of pregnant women living with HIV2017: 75 % of pregnant women living with HIV2018: 67 % of pregnant women living with HIV2019: 83 % of pregnant women living with HIV2020: 68 % of pregnant women living with HIV2021: 81 % of pregnant women living with HIV2022: 92 % of pregnant women living with HIV2023: 87 % of pregnant women living with HIV2024: 79 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

The most recent figure for antiretroviral therapy coverage for pmtct in Moldova is 79.0%, measured in 2024.

The figure is down 9.2% on the previous year and up 36.2% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Moldova peaked at 92.0% in 2022 and was at its lowest, 0.0%, in 2000.

Moldova ranks 43rd of 84 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Moldova, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Moldova, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 2.0%
2004 14.0% +600.0%
2005 15.0% +7.1%
2006 26.0% +73.3%
2007 29.0% +11.5%
2008 51.0% +75.9%
2009 42.0% -17.6%
2010 47.0% +11.9%
2011 47.0% +0.0%
2012 54.0% +14.9%
2013 55.0% +1.9%
2014 58.0% +5.5%
2015 67.0% +15.5%
2016 75.0% +11.9%
2017 75.0% +0.0%
2018 67.0% -10.7%
2019 83.0% +23.9%
2020 68.0% -18.1%
2021 81.0% +19.1%
2022 92.0% +13.6%
2023 87.0% -5.4%
2024 79.0% -9.2%

Moldova compared with similar countries

  • Moldova's 79.0% is below the median for upper middle income countries, which is 79.5%, 99% of the median. (22 countries reporting)
  • Moldova's 79.0% is below the median for Europe & Central Asia, which is 91.0%, 87% of the median. (8 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Moldova changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2004 +600.0% 2.0% 14.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 17.9% 0.0% 51.0% 10
2010s 62.8% 47.0% 83.0% 10
2020s 81.4% 68.0% 92.0% 5

Countries ranked near Moldova

  1. 40 South Sudan 81.0% compare
  2. 41 Cape Verde 80.0% compare
  3. 41 Guinea 80.0% compare
  4. 43 Angola 79.0% compare
  5. 43 Guinea-Bissau 79.0% compare
  6. 46 Chad 77.0% compare
  7. 46 Gambia 77.0% compare

See the full ranking of 99 places →

More health data for Moldova

All data for Moldova →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Moldova?
Antiretroviral therapy coverage for pmtct in Moldova was 79.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Moldova?
The highest recorded value was 92.0% in 2022.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Moldova?
The lowest recorded value was 0.0% in 2000.
How does Moldova rank for antiretroviral therapy coverage for pmtct?
Moldova ranks 43rd out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Moldova?
Over the last ten years it is up 36.2%. The long-run trend across the full record is volatile.
Where does this Moldova data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Moldova. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 17 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/moldova/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/moldova/">Antiretroviral therapy coverage for PMTCT in Moldova</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).